Patents by Inventor Lawrence A. Lasky

Lawrence A. Lasky has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-tumor antibody compositions and methods of use
    Patent number: 7435416
    Abstract: The invention provides antibodies targeted at a tumor antigen prevalent on prostate tumors and methods useful in alleviating cancers expressing the antigen, as well as nucleic acids and cells for expressing the antibodies.
    Type: Grant
    Filed: September 8, 2004
    Date of Patent: October 14, 2008
    Assignee: Genetech, Inc.
    Inventors: Brigitte Devaux, Gilbert-Andre Keller, Hartmut Koeppen, Lawrence A. Lasky
  • Novel hematopoietic regulatory factors and methods of use thereof
    Publication number: 20050042655
    Abstract: Disclosed are novel hematopioetic modulating nucleic acid sequences and polypeptides. Also disclosed are methods in which the nucleic acids and polypeptides are utilized in the detection and treatment of hematopoietic disorders.
    Type: Application
    Filed: July 6, 2004
    Publication date: February 24, 2005
    Applicants: Genentech Corporation, Curagen Corporation
    Inventors: David Lewin, Richard Shimkets, Lawrence Lasky, Bruce Taillon, Steven Gold
  • Anti-tumor antibody compositions and methods of use
    Publication number: 20050036942
    Abstract: The invention provides antibodies targeted at a tumor antigen prevalent on prostate tumors and methods useful in alleviating cancers expressing the antigen, as well as nucleic acids and cells for expressing the antibodies.
    Type: Application
    Filed: September 8, 2004
    Publication date: February 17, 2005
    Applicant: Genentech, Inc.
    Inventors: Brigitte Devaux, Gilbert-Andre Keller, Hartmut Koeppen, Lawrence Lasky
  • Anti-tumor antibody compositions and methods of use
    Patent number: 6824780
    Abstract: The invention provides antibodies targeted at a tumor antigen prevalent on prostate tumors and methods useful in alleviating cancers expressing the antigen, as well as nucleic acids and cells for expressing the antibodies.
    Type: Grant
    Filed: October 27, 2000
    Date of Patent: November 30, 2004
    Assignee: Genentech, Inc.
    Inventors: Brigitte Devaux, Gilbert-Andre Keller, Hartmut Koeppen, Lawrence A. Lasky